CPA Applauds President Trump’s Executive Order to Restore U.S. Pharmaceutical Manufacturing
President Trump’s Executive Order is a bold, necessary move to rebuild America’s pharmaceutical industry and protect our citizens.
Democrats on House Oversight Committee Unite Against Tariffs; Witnesses Tout Need for ‘Factories of the Future’ to Compete Against China
Democrats on the Economic Growth, Energy Policy, and Regulatory Affairs Subcommittee—of the House Committee on Oversight and Government Reform—are united against tariffs.
CPA Applauds President Trump for Closing De Minimis Loophole to Chinese Imports
President Trump’s action to close the de minimis loophole for China is a monumental victory for American workers, manufacturers, and national security.
CPA Calls on JPMorgan and Bank of America to Withdraw from CATL IPO
The IPO, widely seen as the first major test of President Trump’s America First Investment Policy (AFIP), directly undermines the President’s February directive to block U.S. investment in companies linked to the Chinese military, human rights abuses, and authoritarian surveillance state.
CPA Supports Strong Action in Section 232 Investigation to Save 250,000 American Jobs in the Timber and Lumber Industry
Foreign imports primarily from Cambodia, Malaysia, Mexico, Thailand, and Vietnam—that are heavily subsidized by China—are destroying American cabinet jobs.
Wall Street’s CATL IPO Test: Will They Stand with American Security or the CCP?
The American people, Congress, and the President have spoken. Now it’s Wall Street’s turn to decide.
Big Ag is Dead Wrong on Trade
Feeding America with abundant, healthy, locally-produced food is as important as any trade or industrial goal. Reinforcing our capacity to feed ourselves makes the nation stronger, safer, and more prosperous, whole the Big Ag status quo blindly follows a globalized model that has left far too many American farms behind.
CPA Applauds Commerce Department’s Final Determinations Confirming China’s Rampant Trade Violations in Solar Imports from Southeast Asia
The Department’s decision confirms what CPA has consistently warned: Chinese solar companies have been illegally circumventing U.S. trade laws through Southeast Asian shell operations, flooding the U.S. market with dumped and subsidized products directly harming the domestic solar manufacturing industry.
Americans Are Dangerously Dependent on Foreign-made Generic Drugs. Tariffs Can Fix That.
Tariffs on pharmaceutical companies isn’t just good economic policy — it benefits national security and public health.
Imports Show Near-Zero Growth Month Over Month As Tariff Reset Begins
Imports did not vanish, but their growth rate was flat at zero percent in February compared to January after nearly two months of importers rushing in orders ahead of tariffs. February goods and services imports were $401 billion, a statistically insignificant change from January, the Bureau of Economic Analysis said.
